To the full analysis
Buyback calculator for Medistim
Medistim stock: key metrics
MEDI.OLMedistim had an operating margin of 28% and a return on invested capital (ROIC) of 50.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 100.0% | 98.7% | 0.0% |
| 2007 | 70.1% | 15.8% | 22.4% |
| 2008 | 71.0% | 17.4% | 9.6% |
| 2009 | 72.7% | 18.2% | 17.8% |
| 2010 | 72.7% | 15.4% | 11.9% |
| 2011 | 73.5% | 15.0% | 9.7% |
| 2012 | 72.8% | 22.6% | 16.6% |
| 2013 | 74.2% | 18.7% | 13.9% |
| 2014 | 74.1% | 20.2% | 14.6% |
| 2015 | 74.1% | 20.1% | 16.2% |
| 2016 | 75.3% | 21.5% | 14.9% |
| 2017 | 75.4% | 22.1% | 16.1% |
| 2018 | 75.4% | 22.9% | 17.7% |
| 2019 | 77.5% | 25.2% | 19.7% |
| 2020 | 78.5% | 26.8% | 19.5% |
| 2021 | 76.8% | 27.8% | 21.8% |
| 2022 | 78.1% | 29.0% | 23.4% |
| 2023 | 78.5% | 25.2% | 19.9% |
| 2024 | 79.8% | 23.3% | 18.5% |
| 2025 | 45.9% | 28.0% | 22.8% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 0.0% | 252.7% | 0.0% |
| 2007 | 30.3% | 32.3% | 22.0% |
| 2008 | 14.2% | 17.6% | 9.3% |
| 2009 | 26.2% | 26.0% | 19.1% |
| 2010 | 17.3% | 23.0% | 12.8% |
| 2011 | 14.5% | 21.6% | 10.4% |
| 2012 | 26.3% | 35.6% | 19.9% |
| 2013 | 21.8% | 24.9% | 15.8% |
| 2014 | 22.5% | 27.1% | 15.4% |
| 2015 | 25.9% | 31.6% | 18.5% |
| 2016 | 23.5% | 31.0% | 18.0% |
| 2017 | 26.0% | 32.0% | 18.9% |
| 2018 | 27.6% | 35.3% | 21.2% |
| 2019 | 29.7% | 36.1% | 20.9% |
| 2020 | 27.0% | 32.8% | 20.1% |
| 2021 | 29.7% | 42.5% | 22.5% |
| 2022 | 31.0% | 49.4% | 23.6% |
| 2023 | 26.1% | 40.2% | 20.5% |
| 2024 | 23.8% | 36.6% | 18.1% |
| 2025 | 34.0% | 50.6% | 24.1% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = NOK 9.5325)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 22 Nov 2024)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.